Gerresheimer (GRRMF) Stock Price, News & Analysis

Company Overview

Gerresheimer AG is a Germany-based healthcare company that develops and manufactures specialty packaging and drug-delivery systems for the pharmaceutical, biotech and cosmetics industries. Its products are designed to protect, store and administer medicines and other sensitive healthcare products.

The company’s portfolio includes glass and plastic containers such as vials, ampoules, bottles and syringes, as well as prefillable syringes, cartridges, inhalers, injection pens and other delivery devices. Gerresheimer also provides solutions for complex drug-delivery applications and supports customers with development, engineering and manufacturing services.

Gerresheimer traces its origins to 1864, when Ferdinand Heye founded a glassworks in Gerresheim, now part of Düsseldorf, Germany. The company has expanded into an international supplier serving pharmaceutical and healthcare customers across Europe, North and South America, and Asia. Its headquarters remain in Düsseldorf.

Key Stats

• Today's Range: $32.20 to $32.20
• 50-Day Range: $29.15 to $33.35
• 52-Week Range: $19.17 to $33.35
• Volume: N/A
• Average Volume: 242 shs
• Market Capitalization: N/A
• P/E Ratio: 14.19
• Dividend Yield: 1.61%
• Price Target: N/A
• Consensus Rating: Reduce

Gerresheimer Stock Analysis - MarketRank™

Gerresheimer scored higher than 25% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Reduce

Consensus Rating

Gerresheimer has received a consensus rating of Reduce. The company's average rating score is 1.80, and is based on no strong buy ratings, no buy ratings, 4 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Gerresheimer has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Gerresheimer is 14.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.29.

Price to Earnings Ratio vs. Sector

The P/E ratio of Gerresheimer is 14.19, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.82.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Gerresheimer has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.

Change versus previous month

Short interest in Gerresheimer has recently decreased by 23.59%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Gerresheimer pays a meaningful dividend of 1.30%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Gerresheimer does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Gerresheimer is 22.82%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Gerresheimer insiders have not sold or bought any company stock.

Percentage Held by Institutions

53.23% of the stock of Gerresheimer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Today: 9/07/2026
• Next Earnings (Estimated): 9/16/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:GRRMF
• CIK: N/A
• Web: www.gerresheimer.com
• Phone: 49 211 6181 00
• Fax: N/A
• Employees: 11,947
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 14.19
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A